Taizhou Mabtech Pharmaceutical Co.,ltd

This study tested whether a new drug called CMAB015 works as well as the approved drug secukinumab for adults with moderate to severe plaque psoriasis. 336 participants received injections of either drug over 48 weeks. The main goal was to see if at least 75% of skin symptoms imp…

This study tested a new version of the allergy drug omalizumab (called CMAB007) against the approved drug Xolair. It involved 114 healthy Chinese men who received a single dose of one of the two drugs. The goal was to compare how the drugs move through the body, their safety, and…